Scott M. Rocklage, 10% Owner at Crinetics Pharmaceuticals, Inc. (CRNX), sold 309,678 shares at $24.25 ($7.5M) on 2019-03-18, disclosed to the SEC on 2019-03-20.
Open-market sale of $7.5M CRNX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.25 | 6,194 | $150K | 2.0% |
| 2 | $24.25 | 6,194 | $150K | 2.0% |
| 3 | $24.25 | 148,645 | $3.6M | 48.0% |
| 4 | $24.25 | 148,645 | $3.6M | 48.0% |
| Total | $24.25 avg | 309,678 | $7.5M | 100% |
| Filing → |
| APRE | SELL | 2020-06-18 | $8.0M | — | Filing → |
| APRE | SELL | 2020-06-15 | $7.0M | — | Filing → |
| APRE | SELL | 2020-05-21 | $9.0M | — | Filing → |